EVENTS
2024/10/24
250129ネットセミナー次世代ゼブラフィッシュ創薬の展開
2024/09/10
Zebrafish-Based Oncocardiology and Onconephrology
2024/07/05
新しいハイスループット個別ゼブラフィッシュ腎毒性スクリーニングシステムの創生と応用
2024/07/05
第51回日本毒性学会学術年会
》discovery of stanniocalcin1 as cardiotoxic defence gene
2024/04/25
We have discovered stanniocalcin1 as cardiotoxic defence gene in 2015. the potential clinical applications of stanniocalcin in oncocardiology include its use as a biomarker for cancer therapy-induced cardiotoxicity, its potential as a therapeutic target for cardioprotection, and its role in regulating calcium homeostasis, which may be relevant for managing calcium-related cardiovascular complications in cancer patients.